Clinical Trial Update: Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravenous LC28-0126 administered immediately before PCI in patients with ST-segment elevation myocardial infarction (STEMI) has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• LC28-0126

Snippet

Sponsor: LG Life Sciences | Conditions: ST-segment Elevation Myocardial Infarction | Phase 2 | Status: COMPLETED